Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?
Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?
复制标题
DOI：
10.1007/s00270-010-0012-y
复制
发表时间：
2011-02
影响因子：
2.9
通讯作者：
Geschwind, Jean-Francois H.
中科院分区：
文献类型：
--
作者：
Liapi, Eleni;Geschwind, Jean-Francois H.
传统的经导管动脉化疗栓塞术和药物洗脱微珠化疗栓塞术正越来越多地在世界各地的许多机构交替进行。随着这两种疗法继续在许多II期和III期研究中进行测试，并与其他疗法，特别是靶向药物，用于治疗原发性和转移性肝癌，审查它们的现状并评估它们对患者生存的影响是当务之急。本文从患者的选择、适应症、禁忌症、技术、材料、安全性和临床疗效等方面对常规化疗栓塞术和药物洗脱微珠化疗栓塞术的临床效果进行了评价。
Conventional transcatheter arterial chemoembolization and chemoembolization with drug-eluting beads are increasingly being performed interchangeably in many institutions throughout the world. As both therapies continue to being tested in many phase II and III studies and in combination with other therapies, especially targeted agents, for treatment of primary and metastatic liver cancer, it is imperative to review their current status and evaluate their impact on patient survival. This review critically assesses patient selection, indications, contraindications, techniques, materials, safety, and clinical outcomes of patients treated with conventional chemoembolization and chemoembolization with drug-eluting beads.
登录
查看更多内容
影响因子：
8.8
作者：
Bhattacharya, S;Dhillon, AP;Winslet, MC;Davidson, BR;Shukla, N;Gupta, SD;AlMufti, R;Hobbs, KEF
通讯作者：
Hobbs, KEF
影响因子：
2.9
作者：
Grosso, Maurizio;Vignali, Claudio;Sarti, Ilaria
通讯作者：
Sarti, Ilaria
DOI：
10.1016/j.jvir.2008.01.030
发表时间：
2008-06-01
影响因子：
2.9
作者：
de Baere, Thierry;Deschamps, Frederic;Hechellhammer, Lukas
通讯作者：
Hechellhammer, Lukas
影响因子：
6.2
作者：
Gupta, S;Johnson, MM;Yao, JC
通讯作者：
Yao, JC
影响因子：
4.3
作者：
Cheng, Hong-Yan;Shou, Yi;Jia, Yu-Chen
通讯作者：
Jia, Yu-Chen